Skip to content

Clinical trials

Phase 3 Seizures trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Seizures Phase: Phase 3 Country / region: Mexico Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20052
20062
20073
20081
20111
20161
20171
20222
20233
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting3
Enrolling by invitation2
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Longboard Pharmaceuticals3
Novartis Pharmaceuticals3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Xenon Pharmaceuticals Inc.3
GlaxoSmithKline2
UCB Pharma2
Amzell1
Eisai Inc.1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
SK Life Science, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Seizures21
Epilepsy17
Epilepsies, Partial7
Lennox Gastaut Syndrome3
Neurodevelopmental Disorders3
Epilepsies, Myoclonic2
Central Nervous System Diseases1
Epilepsy, Complex Partial1
Epileptic Syndromes1
Spasms, Infantile1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.